Delsignore R, Baroni C M, Crotti G, Mineo F, Butturini U, Ascalone V, Cisternino M
Chemotherapy. 1983;29(3):157-62. doi: 10.1159/000238191.
The disposition and bioavailability of ceftriaxone, a novel cephalosporin, was studied in 7 healthy volunteers after a single 1.5-gram intramuscular administration in comparison with the same dose given by the intravenous route. The plasma levels were measured by means of a high-performance liquid chromatography method up to 48 h after administration. Comparable areas under plasma concentration-time curve (AUC) and biological half-life were obtained proving that ceftriaxone, if assessed by conventional methods, is completely bioavailable when given by the intramuscular route. However, taking into account its nonlinear pharmacokinetics it becomes obvious that direct comparison of AUC values generally leads to a certain overestimation of bioavailability after extravascular administration. This aspect is briefly discussed.
对7名健康志愿者单次肌内注射1.5克新型头孢菌素头孢曲松后的处置和生物利用度进行了研究,并与静脉注射相同剂量进行比较。给药后48小时内,采用高效液相色谱法测定血浆水平。获得了可比的血浆浓度-时间曲线下面积(AUC)和生物半衰期,证明头孢曲松若采用传统方法评估,肌内给药时生物利用度完全。然而,考虑到其非线性药代动力学,很明显,AUC值的直接比较通常会导致血管外给药后生物利用度的一定高估。简要讨论了这一方面。